Granules India has received USFDA approval for its Abbreviated New Drug Applications (ANDA) for Ibuprofen Tablets USP, 400 mg, 600 mg and 800 mg.
Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.
